Abstract
Covid-19 pandemic has the potential to modify the presentation of neuromuscular disorders. We describe one such patient who had COVID-19 infection along with dermatomyositis. He had typical rash and muscle weakness but also had rhabdomyolysis at presentation and muscle biopsy showed necrotic muscle fibres. He was treated with intravenous steroids and rituximab and showed gradual recovery.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
